NPJ vaccines

Keyphrases

Publications

volume 9, number 1, 2024

Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Emeline Vernhes, Linda Larbi Chérif, Nicolas Ducrot, Clément Vanbergue, Malika Ouldali, Lena Zig, N'diaye Sidibe, Sylviane Hoos, Luis Ramirez-Chamorro, Madalena Renouard, Ombeline Rossier, Patrick England, Guy Schoehn, Pascale Boulanger, Karim Benihoud
Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design. NPJ vaccines 9 (1) (2024)
Chan Tang, Annemiek Verwilligen, Jerald Sadoff, Boerries Brandenburg, Eveline Sneekes-Vriese, Tom van den Kerkhof, Lieve Dillen, Lucy Rutten, Jarek Juraszek, Katleen Callewaert, Sarah Janssen, Jeroen Huizingh, Zelda Euler, Tom Schilperoord, Marc Verhemeldonck, Johannes P M Langedijk, Jenny Hendriks, Daniel J Stieh
Absolute quantitation of binding antibodies from clinical samples. NPJ vaccines 9 (1) (2024)
Zachary MacMillen, Kiara Hatzakis, Adrian Simpson, Melanie J Shears, Felicia Watson, Jesse H Erasmus, Amit P Khandhar, Brandon K Sack, Sean C Murphy, Steven G Reed, James W Davie, Marion Avril
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. NPJ vaccines 9 (1) (2024)
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, Savita Singh, Priyanka Sharma, Rucha Chandwaskar, Mudita Gosain, Sreevatsan Raghavan, Deepika Rathna Murugesan, Pallavi Kshetrapal, Ramachandran Thiruvengadam, Shinjini Bhatnagar, Anil Kumar Pandey, Pramod Kumar Garg, Amit Awasthi
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation. NPJ vaccines 9 (1) (2024)
Barbara Bravi
Development and use of machine learning algorithms in vaccine target selection. NPJ vaccines 9 (1) (2024)
Francisco José Martínez, Michael White, Micheline Guillotte-Blisnick, Christèle Huon, Alix Boucharlat, Fabrice Agou, Patrick England, Jean Popovici, Mimi M Hou, Sarah E Silk, Jordan R Barrett, Carolyn M Nielsen, Jenny M Reimer, Paushali Mukherjee, Virander Singh Chauhan, Angela M Minassian, Simon J Draper, Chetan E Chitnis
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial. NPJ vaccines 9 (1) (2024)
Puthupparampil V Scaria, Nicole Roth, Kim Schwendt, Olga V Muratova, Nada Alani, Lynn E Lambert, Emma K Barnafo, Christopher G Rowe, Irfan U Zaidi, Kelly M Rausch, David L Narum, Benjamin Petsch, Patrick Emmet Duffy
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response. NPJ vaccines 9 (1) (2024)
Daisy Woellner-Santos, Ana Carolina Tahira, João V M Malvezzi, Vinicius Mesel, David A Morales-Vicente, Monalisa M Trentini, Lázaro M Marques-Neto, Isaac A Matos, Alex I Kanno, Adriana S A Pereira, André A R Teixeira, Ricardo Jose Giordano, Luciana C C Leite, Carlos A B Pereira, Ricardo DeMarco, Murilo Sena Amaral, Sergio Verjovski-Almeida
Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques. NPJ vaccines 9 (1) (2024)
Emeline Vernhes, Linda Larbi Chérif, Nicolas Ducrot, Clément Vanbergue, Malika Ouldali, Lena Zig, N'diaye Sidibe, Sylviane Hoos, Luis Ramirez-Chamorro, Madalena Renouard, Ombeline Rossier, Patrick England, Guy Schoehn, Pascale Boulanger, Karim Benihoud
Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design. NPJ vaccines 9 (1) (2024)
Eriberto Noel Natali, Alexander Horst, Patrick Meier, Victor Greiff, Mario Nuvolone, Lmar Marie Babrak, Katja Fink, Enkelejda Miho
The dengue-specific immune response and antibody identification with machine learning. NPJ vaccines 9 (1) (2024)
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, Savita Singh, Priyanka Sharma, Rucha Chandwaskar, Mudita Gosain, Sreevatsan Raghavan, Deepika Rathna Murugesan, Pallavi Kshetrapal, Ramachandran Thiruvengadam, Shinjini Bhatnagar, Anil Kumar Pandey, Pramod Kumar Garg, Amit Awasthi
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation. NPJ vaccines 9 (1) (2024)
Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols, Daniel J Sheward, Changil Kim, Alberto Cagigi, Matthew Gagne, Brandon Davis, Daritza Germosen, Vicky Roy, Galit Alter, Hélène Letscher, Jérôme Van Wassenhove, Wesley Gros, Anne-Sophie Gallouët, Roger Le Grand, Harold Kleanthous, Mimi Guebre-Xabier, Ben Murrell, Nita Patel, Gregory Glenn, Gale Smith, Karin Loré
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2. NPJ vaccines 9 (1) (2024)
Saber Imani, Oya Tagit, Chantal Pichon
Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact. NPJ vaccines 9 (1) (2024)
Eriberto Noel Natali, Alexander Horst, Patrick Meier, Victor Greiff, Mario Nuvolone, Lmar Marie Babrak, Katja Fink, Enkelejda Miho
The dengue-specific immune response and antibody identification with machine learning. NPJ vaccines 9 (1) (2024)
Zachary MacMillen, Kiara Hatzakis, Adrian Simpson, Melanie J Shears, Felicia Watson, Jesse H Erasmus, Amit P Khandhar, Brandon K Sack, Sean C Murphy, Steven G Reed, James W Davie, Marion Avril
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. NPJ vaccines 9 (1) (2024)
Sriharshita Musunuri, Payton A B Weidenbacher, Peter S Kim
Bringing immunofocusing into focus. NPJ vaccines 9 (1) (2024)
Puthupparampil V Scaria, Nicole Roth, Kim Schwendt, Olga V Muratova, Nada Alani, Lynn E Lambert, Emma K Barnafo, Christopher G Rowe, Irfan U Zaidi, Kelly M Rausch, David L Narum, Benjamin Petsch, Patrick Emmet Duffy
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response. NPJ vaccines 9 (1) (2024)
Zachary MacMillen, Kiara Hatzakis, Adrian Simpson, Melanie J Shears, Felicia Watson, Jesse H Erasmus, Amit P Khandhar, Brandon K Sack, Sean C Murphy, Steven G Reed, James W Davie, Marion Avril
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. NPJ vaccines 9 (1) (2024)
Emeline Vernhes, Linda Larbi Chérif, Nicolas Ducrot, Clément Vanbergue, Malika Ouldali, Lena Zig, N'diaye Sidibe, Sylviane Hoos, Luis Ramirez-Chamorro, Madalena Renouard, Ombeline Rossier, Patrick England, Guy Schoehn, Pascale Boulanger, Karim Benihoud
Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design. NPJ vaccines 9 (1) (2024)
Puthupparampil V Scaria, Nicole Roth, Kim Schwendt, Olga V Muratova, Nada Alani, Lynn E Lambert, Emma K Barnafo, Christopher G Rowe, Irfan U Zaidi, Kelly M Rausch, David L Narum, Benjamin Petsch, Patrick Emmet Duffy
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response. NPJ vaccines 9 (1) (2024)
Daisy Woellner-Santos, Ana Carolina Tahira, João V M Malvezzi, Vinicius Mesel, David A Morales-Vicente, Monalisa M Trentini, Lázaro M Marques-Neto, Isaac A Matos, Alex I Kanno, Adriana S A Pereira, André A R Teixeira, Ricardo Jose Giordano, Luciana C C Leite, Carlos A B Pereira, Ricardo DeMarco, Murilo Sena Amaral, Sergio Verjovski-Almeida
Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques. NPJ vaccines 9 (1) (2024)
Francisco José Martínez, Michael White, Micheline Guillotte-Blisnick, Christèle Huon, Alix Boucharlat, Fabrice Agou, Patrick England, Jean Popovici, Mimi M Hou, Sarah E Silk, Jordan R Barrett, Carolyn M Nielsen, Jenny M Reimer, Paushali Mukherjee, Virander Singh Chauhan, Angela M Minassian, Simon J Draper, Chetan E Chitnis
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial. NPJ vaccines 9 (1) (2024)
Girmay Desalegn, Chitradevi S Tamilselvi, Jose M Lemme-Dumit, Shannon J Heine, Dylan Dunn, Esther Ndungo, Neeraj Kapoor, Edwin V Oaks, Jeff Fairman, Marcela F Pasetti
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate. NPJ vaccines 9 (1) (2024)
Ryuta Uraki, Masaki Imai, Mutsumi Ito, Seiya Yamayoshi, Maki Kiso, Nao Jounai, Kazuki Miyaji, Kiyoko Iwatsuki-Horimoto, Fumihiko Takeshita, Yoshihiro Kawaoka
An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. NPJ vaccines 9 (1) (2024)
Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols, Daniel J Sheward, Changil Kim, Alberto Cagigi, Matthew Gagne, Brandon Davis, Daritza Germosen, Vicky Roy, Galit Alter, Hélène Letscher, Jérôme Van Wassenhove, Wesley Gros, Anne-Sophie Gallouët, Roger Le Grand, Harold Kleanthous, Mimi Guebre-Xabier, Ben Murrell, Nita Patel, Gregory Glenn, Gale Smith, Karin Loré
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2. NPJ vaccines 9 (1) (2024)
Ryuta Uraki, Masaki Imai, Mutsumi Ito, Seiya Yamayoshi, Maki Kiso, Nao Jounai, Kazuki Miyaji, Kiyoko Iwatsuki-Horimoto, Fumihiko Takeshita, Yoshihiro Kawaoka
An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. NPJ vaccines 9 (1) (2024)
Eriberto Noel Natali, Alexander Horst, Patrick Meier, Victor Greiff, Mario Nuvolone, Lmar Marie Babrak, Katja Fink, Enkelejda Miho
The dengue-specific immune response and antibody identification with machine learning. NPJ vaccines 9 (1) (2024)
Barbara Bravi
Development and use of machine learning algorithms in vaccine target selection. NPJ vaccines 9 (1) (2024)
Devi Jenika, Saranya Pounraj, David Wibowo, Leonhard M Flaxl, Bernd H A Rehm, Justine D Mintern
In vivo assembly of epitope-coated biopolymer particles that induce anti-tumor responses. NPJ vaccines 9 (1) (2024)
Barbara Bravi
Development and use of machine learning algorithms in vaccine target selection. NPJ vaccines 9 (1) (2024)
Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols, Daniel J Sheward, Changil Kim, Alberto Cagigi, Matthew Gagne, Brandon Davis, Daritza Germosen, Vicky Roy, Galit Alter, Hélène Letscher, Jérôme Van Wassenhove, Wesley Gros, Anne-Sophie Gallouët, Roger Le Grand, Harold Kleanthous, Mimi Guebre-Xabier, Ben Murrell, Nita Patel, Gregory Glenn, Gale Smith, Karin Loré
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2. NPJ vaccines 9 (1) (2024)
Saber Imani, Oya Tagit, Chantal Pichon
Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact. NPJ vaccines 9 (1) (2024)
Devi Jenika, Saranya Pounraj, David Wibowo, Leonhard M Flaxl, Bernd H A Rehm, Justine D Mintern
In vivo assembly of epitope-coated biopolymer particles that induce anti-tumor responses. NPJ vaccines 9 (1) (2024)
Sriharshita Musunuri, Payton A B Weidenbacher, Peter S Kim
Bringing immunofocusing into focus. NPJ vaccines 9 (1) (2024)
Zachary MacMillen, Kiara Hatzakis, Adrian Simpson, Melanie J Shears, Felicia Watson, Jesse H Erasmus, Amit P Khandhar, Brandon K Sack, Sean C Murphy, Steven G Reed, James W Davie, Marion Avril
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. NPJ vaccines 9 (1) (2024)
Sriharshita Musunuri, Payton A B Weidenbacher, Peter S Kim
Bringing immunofocusing into focus. NPJ vaccines 9 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Francisco José Martínez, Michael White, Micheline Guillotte-Blisnick, Christèle Huon, Alix Boucharlat, Fabrice Agou, Patrick England, Jean Popovici, Mimi M Hou, Sarah E Silk, Jordan R Barrett, Carolyn M Nielsen, Jenny M Reimer, Paushali Mukherjee, Virander Singh Chauhan, Angela M Minassian, Simon J Draper, Chetan E Chitnis
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial. NPJ vaccines 9 (1) (2024)
Chan Tang, Annemiek Verwilligen, Jerald Sadoff, Boerries Brandenburg, Eveline Sneekes-Vriese, Tom van den Kerkhof, Lieve Dillen, Lucy Rutten, Jarek Juraszek, Katleen Callewaert, Sarah Janssen, Jeroen Huizingh, Zelda Euler, Tom Schilperoord, Marc Verhemeldonck, Johannes P M Langedijk, Jenny Hendriks, Daniel J Stieh
Absolute quantitation of binding antibodies from clinical samples. NPJ vaccines 9 (1) (2024)
Wonyeong Jung, Dansu Yuan, Benjamin P Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P McNamara, Sue Ann Costa Clemens
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike. NPJ vaccines 9 (1) (2024)
Devi Jenika, Saranya Pounraj, David Wibowo, Leonhard M Flaxl, Bernd H A Rehm, Justine D Mintern
In vivo assembly of epitope-coated biopolymer particles that induce anti-tumor responses. NPJ vaccines 9 (1) (2024)
Wonyeong Jung, Dansu Yuan, Benjamin P Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P McNamara, Sue Ann Costa Clemens
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike. NPJ vaccines 9 (1) (2024)
Chan Tang, Annemiek Verwilligen, Jerald Sadoff, Boerries Brandenburg, Eveline Sneekes-Vriese, Tom van den Kerkhof, Lieve Dillen, Lucy Rutten, Jarek Juraszek, Katleen Callewaert, Sarah Janssen, Jeroen Huizingh, Zelda Euler, Tom Schilperoord, Marc Verhemeldonck, Johannes P M Langedijk, Jenny Hendriks, Daniel J Stieh
Absolute quantitation of binding antibodies from clinical samples. NPJ vaccines 9 (1) (2024)
Leonie Mayer, Leonie M Weskamm, Anahita Fathi, Maya Kono, Jasmin Heidepriem, Verena Krähling, Sibylle C Mellinghoff, My Linh Ly, Monika Friedrich, Svenja Hardtke, Saskia Borregaard, Thomas Hesterkamp, Felix F Loeffler, Asisa Volz, Gerd Sutter, Stephan Becker, Christine Dahlke, Marylyn Martina Addo
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans. NPJ vaccines 9 (1) (2024)
Filippo Carboni, Roberta Cozzi, Giacomo Romagnoli, Giovanna Tuscano, Cristiana Balocchi, Giada Buffi, Margherita Bodini, Cecilia Brettoni, Fabiola Giusti, Sara Marchi, Giulia Brogioni, Barbara Brogioni, Paolo Cinelli, Luigia Cappelli, Chiara Nocciolini, Silvia Senesi, Claudia Facciotti, Elisabetta Frigimelica, Monica Fabbrini, Daniela Stranges, Silvana Savino, Domenico Maione, Roberto Adamo, Benjamin Wizel, Immaculada Margarit, Maria Rosaria Romano
Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles. NPJ vaccines 9 (1) (2024)
Daisy Woellner-Santos, Ana Carolina Tahira, João V M Malvezzi, Vinicius Mesel, David A Morales-Vicente, Monalisa M Trentini, Lázaro M Marques-Neto, Isaac A Matos, Alex I Kanno, Adriana S A Pereira, André A R Teixeira, Ricardo Jose Giordano, Luciana C C Leite, Carlos A B Pereira, Ricardo DeMarco, Murilo Sena Amaral, Sergio Verjovski-Almeida
Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques. NPJ vaccines 9 (1) (2024)
Margaretha L M Prins, Geert V T Roozen, Cilia R Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P Kuiper, Corine Prins, Jacqueline J Janse, Olivia A C Lamers, Jan Pieter R Koopman, Annelieke C Kruithof, Ingrid M C Kamerling, Romy C Dijkland, Alicia C de Kroon, Shohreh Azimi, Mariet C W Feltkamp, Marjan Kuijer, Simon P Jochems, Mirjam H M Heemskerk, Frits Richard Rosendaal, Meta Roestenberg, Leo G Visser, Anna H E Roukens
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial. NPJ vaccines 9 (1) (2024)
Margaretha L M Prins, Geert V T Roozen, Cilia R Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P Kuiper, Corine Prins, Jacqueline J Janse, Olivia A C Lamers, Jan Pieter R Koopman, Annelieke C Kruithof, Ingrid M C Kamerling, Romy C Dijkland, Alicia C de Kroon, Shohreh Azimi, Mariet C W Feltkamp, Marjan Kuijer, Simon P Jochems, Mirjam H M Heemskerk, Frits Richard Rosendaal, Meta Roestenberg, Leo G Visser, Anna H E Roukens
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial. NPJ vaccines 9 (1) (2024)
Girmay Desalegn, Chitradevi S Tamilselvi, Jose M Lemme-Dumit, Shannon J Heine, Dylan Dunn, Esther Ndungo, Neeraj Kapoor, Edwin V Oaks, Jeff Fairman, Marcela F Pasetti
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate. NPJ vaccines 9 (1) (2024)